F.M.J. Debruyne

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.

P P Bringuier, Rainy Umbas, H. Ewout Schaafsma et al. · PubMed · 1993 · 358 citations

Pathology, Tumor Biology, Bladder Tumors +17

Factors affecting recurrence and progression in superficial bladder tumours

K.H. Kurth, L. Denis, Ch. Bouffioux et al. · European Journal of Cancer · 1995 · 283 citations

Urological Research, Urology, Surgical Oncology +5

Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia

F.M.J. Debruyne, A Jardin, D. Colloi et al. · European Urology · 1998 · 227 citations

Urology, Sustained-release Alfuzosin, Medicine +3

Diagnosis and treatment of 409 patients with prostatitis syndromes

Jean de la Rosette, M. Hubregtse, E.J.H. Meuleman et al. · Urology · 1993 · 200 citations

Urology, Clinical Finding, Clinical Case Report +3

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 198 citations · Full text

Tumour Necrosis Factor, Urology, Cancer Immunosurveillance +7